Strawberry Creek Ventures Community Newsletter — July 2022

Content at the intersection of entrepreneurship, venture capital, and our UC Berkeley community.

Written by

Matt Caspari

Published on


2 min

IN THIS ISSUE: Feature on our investment in Gilgamesh Pharmaceuticals; portfolio news on Classiq, Lacework, Mainspring Energy, and MeliBio; Cal co-funds outdoor space for Berkeley unhoused population; and more.

Strawberry Creek Portfolio Spotlight

Gilgamesh Pharmaceuticals is working to reshape the treatment of mental illness by creating a portfolio of novel compounds that capture the therapeutic benefits of psychedelics. Strawberry Creek participated in a $27 million Series A led by Prime Movers Lab. Read Feature Story » 


Thinking of becoming an investor? Access Materials »

Updates From Your Managing Partner

We invite existing investors to visit your Club portal for updates from Managing Partner Matt Caspari and our team, including webinars and events, Syndications, portfolio news, and other exclusive content. Visit Club Portal »

Campus and Community Update

The Berkeley community has a brand-new, 3,000-square-foot outdoor space where unhoused people can go during the day to use the bathroom, grab a bite to eat, play board games, listen to music, and relax under the shade of trees and patio umbrellas. The project was funded jointly by Cal and the City of Berkeley. Read More »

What’s New at Alumni Ventures

Our Thoughts on the Venture Market

Like many of our peers, we believe we’re entering into a new part of the venture cycle. We’ve already seen a dramatic reset of public market valuations — with impacts also affecting the private markets.
Read More »

AV Talent Referrals

Interested in joining a cutting-edge startup or know someone who might be? Our portfolio companies are growing and always looking for high-caliber talent. Check out their open positions on our job board. If you find a match, fill out this short form, and we will try to make a personal referral. Visit Job Board »

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit